Tony SEDGWICK, PhD FRCPath
Strategic Advisor and Observer of the Strategic Board
The Founding President of « The Thought Disruptor », Tony Sedgwick is the former CEO of several biotechnology companies (Cambridge Biotechnology Ltd, DanioLabs, Novacta Ltd, Silence Therapeutics) and Board Member (Midian Clinical, Virobiotech, Celentyx, Vantia Therapeutics, Plastid AS, ThioLogics, Microvisk). Tony was the Global Head of clinical operations at Roche for almost 10 years, Tony advises BIOMUNEX in two areas: clinical strategy and strategic coaching. Dr. Sedgwick holds a FRCPath Doctorate in Pathology / Experimental Pathology from St. Bartholomew’s Hospital Medical School (United Kingdom).